Amyotrophic lateral sclerosis. Multisystem degeneration

被引:9
|
作者
Huebers, A. [1 ]
Ludolph, A. C. [1 ]
Rosenbohm, A. [1 ]
Pinkhardt, E. H. [1 ]
Weishaupt, J. H. [1 ]
Dorst, J. [1 ]
机构
[1] Univ Ulm, Univ Klinikum Ulm, Neurol Klin, Oberer Eselsberg 45, D-89081 Ulm, Germany
来源
NERVENARZT | 2016年 / 87卷 / 02期
关键词
Amyotrophic lateral sclerosis; Motor neuron disease; Protein TDP-43; DNA-binding proteins; Nervous system diseases; FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT EXPANSION; SMALL-FIBER NEUROPATHY; EYE-MOVEMENTS; SPINAL-ONSET; ALS; MUTATIONS; TDP-43; DISEASE; PROTEIN;
D O I
10.1007/s00115-015-0030-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is increasing evidence that amyotrophic lateral sclerosis (ALS) has to be regarded as multisystem degeneration rather than as purely a motor neuron disease, as it also includes various dnonmotor symptoms. This modern view has been confirmed by neuropathological and imaging findings. To review recent findings supporting the idea of multisystem degeneration and to describe the implications for diagnostics and therapy. A discussion of recent clinical, imaging, and neuropathological findings is presented. Symptoms of ALS include not only motor symptoms but also cognitive impairment, oculomotor abnormalities, and extrapyramidal and sensory symptoms. As a neuropathological correlate, a systematic spreading of aEurotransactive response DNA binding protein 43 kDa" (TDP-43) over functionally connected cortical structures has been described. Nonmotor symptoms are regularly seen in ALS, although they usually do not dominate the clinical picture. Recent neuropathological findings offer new perspectives for diagnostics and therapy in ALS.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [1] The multisystem degeneration amyotrophic lateral sclerosis - neuropathological staging and clinical translation
    Verde, F.
    Del Tredici, K.
    Braak, H.
    Ludolph, A. C.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2017, 155 (04): : 210 - 227
  • [2] Lead intoxication and amyotrophic lateral sclerosis.
    Couratier, P
    Bernet-Bernady, P
    Truong, T
    Lagrange, E
    Preux, PM
    Lachatre, G
    Vallat, JM
    REVUE NEUROLOGIQUE, 1998, 154 (04) : 345 - 347
  • [3] Progress in the pathogenesis of amyotrophic lateral sclerosis.
    Shaw C.E.
    Al-Chalabi A.
    Leigh N.
    Current Neurology and Neuroscience Reports, 2001, 1 (1) : 69 - 76
  • [4] Electroneuromyographic criteria of amyotrophic lateral sclerosis.
    Pouget, J.
    REVUE NEUROLOGIQUE, 2006, 162 : 4S34 - 4S42
  • [5] The genetics of amyotrophic lateral sclerosis. An update
    Kartanou, C.
    Koutsis, G.
    Panas, M.
    Karadima, G.
    ARCHIVES OF HELLENIC MEDICINE, 2019, 36 (02): : 166 - 175
  • [6] Cognitive impairment and amyotrophic lateral sclerosis.
    DaryAuriol, M
    Ingrand, P
    Bonnaud, V
    Dumas, P
    Neau, JP
    Gil, R
    REVUE NEUROLOGIQUE, 1997, 153 (04) : 244 - 250
  • [7] Formaldehyde Exposure and Amyotrophic Lateral Sclerosis.
    Weisskopf, M. G.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2014, 55 : S25 - S25
  • [8] Evaluation of strength in amyotrophic lateral sclerosis.
    Camplana-Salort, E.
    REVUE NEUROLOGIQUE, 2006, 162 : 4S138 - 4S144
  • [9] Neuropsychological assessment in amyotrophic lateral sclerosis.
    Havet, V.
    REVUE NEUROLOGIQUE, 2006, 162 : 4S151 - 4S157
  • [10] Medical progress: Amyotrophic lateral sclerosis.
    Rowland, LP
    Shneider, NA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22): : 1688 - 1700